HilleVax Funding & Investors
Boston, MA
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.
hillevax.comTotal Amount Raised: $235,000,000
HilleVax Funding Rounds
Post Ipo Equity
$100,000,000
IPO
Unknown
Series Unknown
$135,000,000
Series Unknown Investors
Frazier ManagementSahsen VenturesCatalys PacificSamsara BioCapitalFranklin ResourcesLightspeed Venture PartnersBiotechnology Value FundPerceptive AdvisorsQiming Venture Partners USARichard King Mellon FoundationRa Capital ManagementGreenspring AssociatesAbingworthDeerfield Management
Funding info provided by Diffbot.